SYK · News · 20260923N

Manufacturing And Capacity

STRYKER CORP · 2026-09-23 · Importance 37 · Surprise 42

Stryker’s previously believed-resolved peripheral vascular manufacturing issue reportedly remains unresolved. The disclosure caused Stryker shares to fall $26.70, or 8.8%, on September 8, according to the third-party report. The issue indicates continued execution risk in the peripheral vascular product manufacturing process.

Key facts

• Investors saw the price of Stryker shares fall $26.70 (-8.8%) on September 8, 2026 after the company's CFO revealed a previously-thought resolved manufacturing issue persists. source
• The company disclosed that a previously-thought resolved manufacturing issue persists (disclosure made by the CFO). source